1. Effects of MMF treatment in patients with SLE
Measure
Baseline
After treatment p
Average steroid dose (mg/d)
17.95
10.86
<0.0001
ESR (mm/h)
38.2
29.19
0.003
Anti-dsDNA (IU/mL)
47.41
30.3
0.004
ECLAM
3.83
2.49
Complement C3 (g/L)
0.66
0.84
Pisoni CN et al. J Rheumatol 2005; 32:

2. Effects of MMF treatment in patients with lupus nephritis
Measure
Baseline
After treatment p
Average steroid dose (mg/d)
17.71
9.38
<0.0001
24-h proteinuria (g/24 h)
3.01
1.85
0.001
Pisoni CN et al. J Rheumatol 2005; 32: